[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339339-105":59,"doc-detail-339339-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advancements-and-current-trends-in-tumor-treating-fields-a-scientometric-analysis-review-article","Advancements and current trends in tumor treating fields: a scientometric analysis - Review Article","","Tumor treating fields (TTFields) therapy is a novel noninvasive cancer treatment approved by the FDA for recurrent and newly diagnosed glioblastoma as well as malignant pleural mesothelioma. Extensive clinical and preclinical research has made TTFields a high-interest topic, motivating a scientometric analysis to map publication and citation patterns over time, top countries and institutions, leading authors and journals, key references, and current research status. Recent years show stable high publication output and rapidly rising citations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advancements-and-current-trends-in-tumor-treating-fields-a-scientometric-analysis-review-article/339339/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advancements-and-current-trends-in-tumor-treating-fields-a-scientometric-analysis-review-article/339339.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is tumor treating fields (TTFields) therapy and what cancers is it approved for?","Question",{"text":112,"@type":113},"TTFields is a noninvasive cancer therapy based on alternating electric fields. It has FDA approval for recurrent and newly diagnosed glioblastoma and malignant pleural mesothelioma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the scientometric analysis in this review aim to reveal?",{"text":117,"@type":113},"It analyzes distributions such as annual publications and citations, countries and institutions, authors, journals, and references, and identifies research status and hot topics.",{"name":119,"@type":110,"acceptedAnswer":120},"Which research areas and cancer types dominate current TTFields studies?",{"text":121,"@type":113},"Keyword analyses point to clinical applications and antitumor mechanisms as the two main parts of current work. Most clinical trials focus on glioblastoma, while other cancers including lung cancer (especially non-small cell lung cancer) and hepatic cancer are also studied.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339339,1790717113,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","’Review Article  \nAdvancements and current trends in tumor treating ﬁelds: a scientometric analysis  \nYang Xing, BSca , Feroza Yasinjan, BSca , Jiayue Cui, MD, PhDb , Yizhao Peng, MSca , Minghua He, BScc , Wenhui Liu, MScb , Xinyu Hong, MD, PhDa,*  \nAbstract   \nTumor treating ﬁelds (TTFields) therapy is a novel and effective noninvasive cancer therapy, and it has been approved by FDA in the treatment of recurrent and newly diagnosed glioblastoma, and malignant pleural mesothelioma. Moreover, TTFields therapy has been widely studied in both clinical trials and preclinical studies in recent years. Based on its high efﬁcacy, research on TTFields therapy has been a hot topic. Thus, the authors made this scientometric analysis of TTﬁelds to reveal the scientometric distributions such as annual publications and citations, countries and institutions, authors, journals, references, and more importantly, research status and hot topics of the ﬁeld. In recent years, publication numbers have been stable at high values, and citation numbers have been increasing greatly. The United States and Israel were the top two countries with the highest publication numbers, followed by Germany and Switzerland. Scientometric analyses of keywords indicated that clinical applications and antitumor mechanisms are probably the two main parts of current research on TTﬁelds. Most clinical trials of TTﬁelds focus on the treatment of glioblastoma. And a variety of other cancers such as lung cancer especially nonsmall cell lung cancer, hepatic cancer, other brain tumors, etc. have also been studied in both clinical trials and preclinical studies.  \nKeywords: GBM, glioma, scientometric analysis, TTﬁelds, tumor treating ﬁelds  \nIntroduction  \nTumor treating ﬁelds (TTFields) therapy is a novel noninvasive cancer therapy, which exerts the antitumor effect based on the alternating electric ﬁelds applied at low-intensity (1–3 V/cm) and intermediate-frequency (100–500 kHz)[1] . In 2011, FDA approved TTFields therapy for the treatment of recurrent or refractory glioblastoma, based on the active results of EF-11 clinical trials (NCT00379470)[2] . Then in 2015, FDA approved TTFields therapy for the treatment of newly diagnosed glioblastoma, based on the excellent results of EF-14 clinical trials (NCT00916409)[3] . Compared with single temozolomide,  \naDepartment of Neurosurgery, The First Hospital of Jilin University, bDepartment of Histology and Embryology, College of Basic Medical Sciences and cCollege of Computer Science and Technology, Jilin University, Changchun, People’s Republic of China  \nYang Xing, Feroza Yasinjan, and Jiayue Cui contributed equally to this work.  \nSponsorships or competing interests that maybe relevant to content are disclosed atthe end of this article.  \n*Corresponding author. Address: The First Hospital of Jilin University, 130021, People’s Republic of China. Tel.: +861 359 640 0500; fax: +860 431 887 822 22. [E-mail: hongxy@jlu.edu.cn](E-mail: hongxy@jlu.edu.cn) (X. Hong).  \nCopyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nInternational Journal of Surgery (2024) 110:2978–2991  \nReceived 6 October 2023; Accepted 26 January 2024  \nPublished online 13 February 2024  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, [www.lww.com/international-journal-of-surgery](www.lww.com/international-journal-of-surgery). [http://dx.doi.org/10.1097/JS9.0000000000001151](http://dx.doi.org/10.1097/JS9.0000000000001151)  \nHIGHLIGHTS  \n• This study represents the ﬁrst scientometric analysis speciﬁcally focused on Tumor treating ﬁelds (TTFields) in all domains.  \n• Through a comprehensive scientometric ","cbCaih961jqtoVoj","https://ap.wps.com/l/cbCaih961jqtoVoj","pdf",1142014,14,"English","# Introduction\n## Abstract\n## Keywords\n## Advances and current trends in TTFields\n## Research mapping: publications, citations, countries, institutions","[{\"question\":\"What is tumor treating fields (TTFields) therapy and what cancers is it approved for?\",\"answer\":\"TTFields is a noninvasive cancer therapy based on alternating electric fields. It has FDA approval for recurrent and newly diagnosed glioblastoma and malignant pleural mesothelioma.\"},{\"question\":\"What does the scientometric analysis in this review aim to reveal?\",\"answer\":\"It analyzes distributions such as annual publications and citations, countries and institutions, authors, journals, and references, and identifies research status and hot topics.\"},{\"question\":\"Which research areas and cancer types dominate current TTFields studies?\",\"answer\":\"Keyword analyses point to clinical applications and antitumor mechanisms as the two main parts of current work. Most clinical trials focus on glioblastoma, while other cancers including lung cancer (especially non-small cell lung cancer) and hepatic cancer are also studied.\"}]","Advancements and current trends in tumor treating fields: a scientometric analysis - Review Article | PDF",1790029709,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/500fbb0d78ba83f2b42640c1dc0c9745.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5ac9594e423488b6595e3f7d58c589a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bd5dbabaf20c93ff1a65089f2fca47f.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbae6b134eb3900feca7461ea8ea8d6d.webp",980,1306]